Inhibition of HIV-1 replication using the CRISPR/cas9-no NLS system as a prophylactic strategy

Globally, it is estimated that 43 million people are living with human immunodeficiency virus type 1 (HIV-1), and there are more than 600,000 acquired immunodeficiency syndrome (AIDS)-related deaths in 2020. The only way to increase the life expectancy of these patients right now is to use combinati...

Descripción completa

Detalles Bibliográficos
Autores principales: Salimi-Jeda, Ali, Esghaei, Maryam, Hossein keyvani, Bokharaei-Salim, Farah, Teimoori, Ali, Abdoli, Asghar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489754/
https://www.ncbi.nlm.nih.gov/pubmed/36158108
http://dx.doi.org/10.1016/j.heliyon.2022.e10483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489754/
https://www.ncbi.nlm.nih.gov/pubmed/36158108
http://dx.doi.org/10.1016/j.heliyon.2022.e10483

Ejemplares similares